Retinopathy of Prematurity:Summary of a Decade

The aim of the study is to evaluate our 10 year experience of retinopathy of prematurity screening.

Completed

Looking for future studies?

Key information

Conditions

Retinopathy of Prematurity Congenital, Hereditary, and Neonatal Diseases and Abnormalities Eye Diseases Infant, Newborn, Diseases Infant, Premature, Diseases Retinal Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Gulhane Military Medical School Training Hospital

Ankara, 06010, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Neonates either with a BW of less than 1501 gram (g) or born at a GA of 34 weeks (wk) or less
selected infants with an unstable clinical course were included

Treatment and study plan

Primary outcomes

Number of neonates developed retinopathy of prematurity

Time frame: ten years
risk factors contributing to ROP development

Time frame: ten years

mechanic ventilation. oxygen therapy, respiratory distress syndrome, sepsis, intraventricular, hemorrhage, blood transfusion v.s

Sponsors and collaborators

Lead sponsor

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Other

Registry information

Important dates

Study start: 1999
Primary completion: 2010
Study completion: 2010
First posted: Jun 2, 2011
Registry last updated: Jun 2, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed